Acute kidney injury increases the rate of major morbidities in cytoreductive surgery and HIPEC.

ABSTRACT:

Introduction

Acute kidney injury (AKI) following cardiovascular surgery has been shown to increase costs and overall morbidity and mortality. The incidence, risk factors, and outcomes of AKI following other types of major surgeries have not been as well characterized. We sought to study the incidence of AKI following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) per the Kidney Disease: Improving Global Outcomes (KDIGO) criteria.

Materials and methods

Patients undergoing CRS and HIPEC between 2013 and 2015 were included. Demographic and perioperative data were compared between patients who experienced AKI versus controls using appropriate statistical analysis between categorical and continuous variables. AKI was recorded by a Certified Prof

SUBMITTER: Naffouje SA 

PROVIDER: S-EPMC6178214 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature